Add like
Add dislike
Add to saved papers

Low-lying electronic states and their nonradiative deactivation of thieno[3,4-b]pyrazine: an ab initio study.

State-averaged complete active space self-consistent field (SA-CASSCF) calculations have been used to locate the four low-lying electronic states of thieno[3,4-b]pyrazine (TP), and their vertical excitation energies and emission energies have been determined by means of the multistate complete active space with second-order perturbation theory (MS-CASPT2) calculations. The present results indicate that the first weak (1)nπ∗ excited state has a C(s)-symmetry structure, unlike two bright (1)ππ∗ excited states in C(2v) symmetry. The predicted vertical excitation energies of the three low-lying excited states in the gas phase are 3.41, 3.92, and 4.13 eV at the restricted-spin coupled-cluster single-double plus perturbative triple excitation [RCCSD(T)] optimized geometry, respectively. On the basis of calculations, a new assignment to the observed spectra of TP was proposed, in which the (1)nπ∗ state should be responsible for the weak absorption centred at 3.54 eV and the two closely spaced (1)ππ∗ states account for the two adjacent absorption bands observed at 3.99 and 4.15 eV. The predicted vertical emission energies lend further support to our assignments. Surface hopping dynamics simulations performed at the SA-CASSCF level suggest that the plausible deactivation mechanism comprises an ultrafast relaxation of the (1)ππ∗ excited states to (1)nπ∗ excited state, followed by a slow conversion to the S(0) ground state via a conical intersection. This internal conversion is accessible, since the MS-CASPT2 predicted energy barrier is ∼0.55 eV, much lower than the Franck-Condon point populated initially under excitation. The dynamical simulations on the low-lying states for 500 fs reveal that the relatively high (1)ππ∗ excited states can be easily trapped in the (1)nπ∗ excited state, which will increase the lifetime of the excited thieno[3,4-b]pyrazine.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app